| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/20/2009 | CA2305621C Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties |
| 01/20/2009 | CA2304770C A use of steroidal saponins for the prophylaxis or treatment of dementia, and novel steroidal saponin compounds |
| 01/20/2009 | CA2296018C Inhibition of hiv-1 replication using oligocarbamate derivatives |
| 01/20/2009 | CA2295599C Novel heterocyclic analogs of diphenylethylene compounds |
| 01/20/2009 | CA2293368C Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives useful for inhibition of farnesyl protein transferase |
| 01/20/2009 | CA2289880C A therapeutic agent for intractable vasculitis |
| 01/20/2009 | CA2279497C The use of levobupivacaine in facial surgery |
| 01/20/2009 | CA2271693C Guanylhydrazones useful for treating diseases associated with t cell activation |
| 01/20/2009 | CA2261040C Pharmaceutical composition comprising combination useful for treatment or prevention of arteriosclerosis or xanthoma |
| 01/20/2009 | CA2246344C A solid non-effervescent compressed dosage form containing racemic ibuprofen |
| 01/20/2009 | CA2236263C Methods for use of mpl ligands with primitive human stem cells |
| 01/20/2009 | CA2220759C 1,4-benzodioxin derivatives |
| 01/20/2009 | CA2214531C Treatment of cytokine growth factor caused disorders |
| 01/20/2009 | CA2213660C Aerosol containing beclamethasone nanoparticle dispersions |
| 01/18/2009 | CA2598948A1 Enhanced formulations of lamotrigine |
| 01/17/2009 | CA2631685A1 Hair conditioning composition containing a non-guar galactomannan polymer derivative |
| 01/15/2009 | WO2009009793A2 Inhibitors of akt/pkb with anti-tumor activity |
| 01/15/2009 | WO2009009778A1 Methods and compositions for the treatment of cancer, tumors, and tumor-related disorders |
| 01/15/2009 | WO2009009768A2 METHODS OF INHIBITING THE FORMATION OF AMYLOID-β DIFFUSABLE LIGANDS USING A ACYLHYDRAZIDE COMPOUNDS |
| 01/15/2009 | WO2009009751A1 A crystalline synthetic intermediate for preparation of a dpp-iv inhibitor and method of purification thereof |
| 01/15/2009 | WO2009009740A1 Fused heteroaryl pyridyl and phenyl benzenesuflonamides as ccr2 modulators for the treament of inflammation |
| 01/15/2009 | WO2009009739A2 Methods and compositions for facilitating cell death of cancer stem cells and for treating cancer |
| 01/15/2009 | WO2009009737A1 Sustained release formulation of active pharmaceuticals in a lipid based sustained release |
| 01/15/2009 | WO2009009669A2 Thermostabilization of proteins |
| 01/15/2009 | WO2009009665A2 O-desmethylvenlafaxine |
| 01/15/2009 | WO2009009655A1 Stromal interacting molecule knockout mouse and uses thereof |
| 01/15/2009 | WO2009009633A1 Substituted heterocyclic ethers and their use in cns disorders |
| 01/15/2009 | WO2009009625A2 Substituted nucleoside derivatives with antiviral and antimicrobial properties |
| 01/15/2009 | WO2009009622A2 Pharmaceutical compositions, including attm, and methods to achieve and maintain a targeted and stable copper status and prevent and treat copper-related central nervous system diseases |
| 01/15/2009 | WO2009009601A1 Method of processing milk |
| 01/15/2009 | WO2009009550A1 Novel compounds as cannabinoid receptor ligands |
| 01/15/2009 | WO2009009531A2 Pyrimidinecarboxamide derivatives for the treatment of hiv infections |
| 01/15/2009 | WO2009009529A1 Treatment of progressive neurodegenerative disease with ibudilast |
| 01/15/2009 | WO2009009480A2 Novel crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy- benzoic acid |
| 01/15/2009 | WO2009009470A1 Stable formulations of thiadiazole derivatiive |
| 01/15/2009 | WO2009009449A2 Phospholipase a2 inhibitors and their use in treating neurological injury and disease |
| 01/15/2009 | WO2009009417A2 Pharmaceutical compositions and methods of preventing, treating, or inhibiting inflammatory diseases, disorders, or conditions of the skin, and diseases, disorders, or conditions associated with collagen depletion |
| 01/15/2009 | WO2009009411A1 Substituted heterocyclic ethers and their use in cns disorders |
| 01/15/2009 | WO2009009393A2 Chromium complexes for improvement of memory and cognitive function |
| 01/15/2009 | WO2009009378A2 Cathepsin-d neuroprotection |
| 01/15/2009 | WO2009009365A1 Compositions and methods for preventing or treating disease caused by polyomavirus infection or reactivation in a mammalian subject |
| 01/15/2009 | WO2009009289A1 Campsiandra angustifolia extract and methods of extracting and using such extract |
| 01/15/2009 | WO2009009278A1 Substituted fluoroethyl ureas as alpha 2 adrenergic agents |
| 01/15/2009 | WO2009009171A2 Methods for preventing or treating infectious diseases using gallium compounds |
| 01/15/2009 | WO2009009132A1 Use of 17alpha-hydroxylase/c17, 20-lyase inhibitors for the treatment of cancer |
| 01/15/2009 | WO2009009122A2 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor |
| 01/15/2009 | WO2009009083A1 R(-)-2-methoxy-11-hydroxyaporphine and derivatives thereof |
| 01/15/2009 | WO2009009061A1 Methods for reducing allergies caused by environmental allergens |
| 01/15/2009 | WO2009009059A1 Spiro compounds as antagonists of tgf-beta |
| 01/15/2009 | WO2009009040A2 Fatty acid compositions and methods of use |
| 01/15/2009 | WO2009009016A1 Combination anti-cancer therapy |
| 01/15/2009 | WO2009009015A1 Quinazolinone t-type calcium channel antagonists |
| 01/15/2009 | WO2009009001A1 Crystalline pyridazine compound |
| 01/15/2009 | WO2009008997A2 Treatment of neuropathic pain |
| 01/15/2009 | WO2009008991A2 Dna-pkcs modulates energy regulation and brain function |
| 01/15/2009 | WO2009008989A1 Modulators of pharmacokinetic properties of therapeutics |
| 01/15/2009 | WO2009008988A1 Immunostimulating polyphosphazene compounds for intradermal immunization |
| 01/15/2009 | WO2009008980A2 Tetrahydropyranochromene gamma secretase inhibitors |
| 01/15/2009 | WO2009008913A2 P1-nonepimerizable ketoamide inhibitors of hcv ns3 protease |
| 01/15/2009 | WO2009008905A1 Hydroxamic acid derivatives of phenoxy-acetic acids and analogs useful as therapeutic agents for treating anthrax poisoning |
| 01/15/2009 | WO2009008901A2 Peptide and small molecule agonises of epa and their uses in diseases |
| 01/15/2009 | WO2009008895A1 Pleasant-tasting ranitidine formulation |
| 01/15/2009 | WO2009008891A1 Methods of enhancing cognitive function using non-peptidic compounds |
| 01/15/2009 | WO2009008890A1 METHODS OF MODIFYING AMYLOID β OLIGOMERS USING NON-PEPTIDIC COMPOUNDS |
| 01/15/2009 | WO2009008885A1 Cholesterol reducing food compositions for animals |
| 01/15/2009 | WO2009008873A1 A gastroretentive composition on the basis of a water-soluble reaction product from a vinyl group- containing precursor |
| 01/15/2009 | WO2009008748A1 Pyrazolo[1,5-a]pyridines and their use in cancer therapy |
| 01/15/2009 | WO2009008717A1 Use of probiotics and fibers for diarrhoea |
| 01/15/2009 | WO2009008696A1 Pharmaceutical composition comprising the combination of a triazolobenzodiazepine and a selective serotonin reuptake inhibitor |
| 01/15/2009 | WO2009008695A1 Pharmaceutical composition comprising the combination of risperidone (benzisoxazolic agent) and clonazepam (benzodiazepinic agent) and use thereof in psychotic disorders and related pathologies |
| 01/15/2009 | WO2009008694A1 Pharmaceutical composition comprising the combination of an anti-depressive agent and an ansiolytic agent for control and treatment of depressive disorders |
| 01/15/2009 | WO2009008683A2 Multi-layered vitamin complex tablet containing ubidecarenone |
| 01/15/2009 | WO2009008632A2 Gastroretentive system containing solubilized drug for maximizing its therapeutic effect for gastritis |
| 01/15/2009 | WO2009008552A1 8-aryl-4-alkylpyrrolo[2,3,4-de]quinolin-5(4h)-one and 8-aryl-4-alkyl-4,5-dihydropyrrolo[2,3,4-de]quinolin-5-ol derivatives |
| 01/15/2009 | WO2009008539A1 Carbostyril derivatives including cilostazol for treating fatty liver |
| 01/15/2009 | WO2009008508A1 Antitumor agent comprising sulfostin and sulfostin-related compound as the active ingredient |
| 01/15/2009 | WO2009008496A1 Anti-hsulf1 antibody |
| 01/15/2009 | WO2009008487A1 Coated preparation |
| 01/15/2009 | WO2009008480A1 Crosslinked polyallylamine or acid addition salt thereof, and use thereof for medical purposes |
| 01/15/2009 | WO2009008461A1 Pharmaceutical composition for disease caused by proliferation of sex hormone sensitive cell |
| 01/15/2009 | WO2009008391A1 Method of producing microparticles to be ingested into the body, microparticles to be ingested into the body and dispersion and medicinal composition containing the same |
| 01/15/2009 | WO2009008371A1 Di(arylamino)aryl compound |
| 01/15/2009 | WO2009008362A1 Method for producing composition containing sialic acid compound |
| 01/15/2009 | WO2009008345A1 Metal complex compound, cancer therapeutic composition comprising the metal complex compound as active ingredient, and intermediate for production of the metal complex compound |
| 01/15/2009 | WO2009008303A1 Process for production of optically active mirtazapine |
| 01/15/2009 | WO2009008120A1 Agent and method for stabilizing membrane protein |
| 01/15/2009 | WO2009008019A1 Stable salts of s-adenosylmethionine and process for the preparation thereof |
| 01/15/2009 | WO2009008009A1 Novel crystalline form b of carvedilol dihydrogen phosphate |
| 01/15/2009 | WO2009008005A1 Pharmaceutical compositions of rifaximin |
| 01/15/2009 | WO2009008004A2 Sustained release formulations of divalproex sodium |
| 01/15/2009 | WO2009007996A2 Cyclodextrin complexes of atovaquone |
| 01/15/2009 | WO2009007992A2 Pharmaceutical composition produced by microprecipitation |
| 01/15/2009 | WO2009007991A2 A new process for preparation of atovaquone and novel intermediates thereof |
| 01/15/2009 | WO2009007987A1 An improved process for the preparation of alfuzosin and its novel polymorph |
| 01/15/2009 | WO2009007975A1 Synergistic combinations for treating hypertension |
| 01/15/2009 | WO2009007839A1 Pharmaceutical compositions and methods of treating dry eye disorders |
| 01/15/2009 | WO2009007814A1 Inhibitors of carbonic anhydrase |
| 01/15/2009 | WO2009007808A1 Combined pharmaceutical composition |
| 01/15/2009 | WO2009007764A2 Pharmaceutical preparations containing highly volatile silicones |
| 01/15/2009 | WO2009007753A2 4- (3-aminopyrazole) -pyrimidine derivativee and their use as tyrosine kinase inhibitors for the treatment of cancer |